About
Epigenetics, Oncolytic viruses
Areas of Focus
Categories
Virus TechnologySmall Molecule PharmaceuticalSan Diego & Southern California
Clinical Trials (16)
View allTotal Trials
16
As Lead Sponsor
16
As Collaborator
0
Total Enrollment
1,042
By Phase
PHASE2: 6PHASE1: 7PHASE3: 2
By Status
COMPLETED: 7TERMINATED: 5RECRUITING: 2ACTIVE_NOT_RECRUITING: 1NO_LONGER_AVAILABLE: 1
Clinical Trials Pipeline15 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05966194Lead Sponsor
RRx-001 for Reducing Oral Mucositis in Patients Receiving Chemotherapy and Radiation for Head and Neck Cancer
PHASE2Recruiting
216 participants
Started: Apr 2, 2024 · Completed: Oct 1, 2025
NCT04525014Lead Sponsor
RRx-001 Given With Irinotecan and Temozolomide for Pediatric Patients With Recurrent or Progressive Malignant Solid and Central Nervous System Tumors
PHASE1Terminated
2 participants
Started: Jan 26, 2023 · Completed: Jul 29, 2024
NCT05566041Lead Sponsor
A Phase 3, Controlled, Open-label, Global Randomized Study of RRx-001 With a Platinum Doublet or a Platinum Doublet in Small Cell Lung Cancer
PHASE3Active, not recruiting
292 participants
Started: Aug 1, 2022 · Completed: Dec 31, 2025
NCT04673942Lead Sponsor
A Study of AdAPT-001 in Subjects With Sarcoma and Refractory Solid Tumors
PHASE2Recruiting
140 participants
Started: Mar 29, 2021 · Completed: Mar 1, 2027
NCT03699956Lead Sponsor
RRx-001 Sequentially With a Platinum Doublet or a Platinum Doublet in Third-Line or Beyond in Patients With Small Cell Lung Cancer
PHASE3Terminated
18 participants
Started: Dec 24, 2018 · Completed: Mar 1, 2024
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...